recomBlot
Enzyme-linked immunosorbent assays (ELISA) for the detection of IgG and IgA antibodies
against the coronavirus SARS-CoV-2 in human serum or plasma.
against the coronavirus SARS-CoV-2 in human serum or plasma.
Mikrogen recomWell SARS-Cov-2 assays are quantitative and qualitative enzyme immunoassays for the detection of IgG and IgA class antibodies to the recombinantly produced SARS-CoV-2 nucleocapsid antigen. Among coronaviruses, this antigen exhibits the strongest immunogenicity.
Advantages
- Highest sensitivity and specificity by using the highly pure and recombinant nucleocapsid antigen
- Separate detection of IgG and IgA antibodies
- Use of single strips possible
Safe and reliable
Fully automatic processing, software-based evaluation and connection to the laboratory information system possible
Flexible and compatible
Combination of all Mikrogen ELISA possible - uniform processing and interchangeable reagents
High Standard
CE mark: The recomWell SARS-CoV-2 tests meet the high standard of the EC Directive 98/79/EC for in vitro diagnostic medical devices.